US Patent Issued to SERODUS on Oct. 14 for "IL-4 derived peptide fragments for use in the treatment of diabetic nephropathy" (Danish Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,535, issued on Oct. 14, was assigned to SERODUS APS (Copenhagen N, Denmark).

"IL-4 derived peptide fragments for use in the treatment of diabetic nephropathy" was invented by Eva Steiness (Hellerup, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to peptide fragments derived from interleukin-4 (IL-4) for the treatment of diabetic nephropathy."

The patent was filed on April 28, 2023, under Application No. 18/724,136.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=5...